Quantitative measurement of cerebral acetylcholinesterase using [11C]physostigmine and positron emission tomography

Journal of Cerebral Blood Flow and Metabolism

Volumn 21, Issue 2, 2001, Pages 114-131

  Blomqvist, Gunnar ^a   Tavitian, Bertrand ^b   Pappata, Sabina ^b   Crouzel, Christian ^b   Jobert, Antoinette ^b   Doignon, Isabelle ^b   Di Giamberardino, Luigi ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

Author keywords

Acetylcholinesterase; Positron emission tomography

Indexed keywords

ACETYLCHOLINESTERASE; BRAIN ENZYME; CARBON 11; CHOLINESTERASE INHIBITOR; PHYSOSTIGMINE; RADIOLIGAND;

ADOLESCENT; ARTICLE; BABOON; BRAIN REGION; CONTROLLED STUDY; CORRELATION FUNCTION; DEGENERATIVE DISEASE; DRUG DISTRIBUTION; ENZYME ACTIVITY; HUMAN; HUMAN EXPERIMENT; MALE; MEASUREMENT; NONHUMAN; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WHITE MATTER;

EID: 0035125941     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-200102000-00003     Document Type: Article

References (35)

1. A new look at the statistical model identification
2. 11C]-D-glucose
3. A tracer kinetic model for measurement of regional acetylcholinesterase activity in the brain using [11C]physostigmine and PET
4. 11C-physostigmine
5. Axonal transport of the molecular forms of acetylcholinesterase in chicken sciatic nerve
6. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type
7. Rate constants of carbamylation and decarbamylation of acetylcholineterase for physostigmine and carbaryl in the presence of an oxime
8. A new and rapid colorimetric determination of acetylcholinesterase activity
9. Brain selective inhibition of acetylcholinesterase: A novel approach to therapy for Alzheimer's disease
10. Brain acetylcholinesterase after acute parathion poisoning: A comparative quantitative histochemical analysis post mortem
11. Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease
12. 11-labeled raclopride in rat striatum using positron emission tomography
13. Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (ACHE) in vivo
14. Brain acetylcholinesterase activity: Validation of a PET tracer model of Alzheimer's disease
15. Measurement of acetylcholinestrase by positron emission tomography in the brains of healthy controls and with Alzheimers disease
16. Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: Alternatives for analysis of an irreversible positron emission tomography tracer for measurement of acetylcholinesterase activity in human brain
17. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer disease
18. 11C]raclopride studies
19. Simplified reference tissue model for PET receptor studies
20. Carbamylation and binding constants for the inhibition of acetylcholinesterase by physostigmine (eserine)
21. Fast nonsupervised 3D registration of PET and MR images of the brain
22. An algorithm for least squares estimation of nonlinear parameters
23. Preserved acetylcholinesterase activity: In aged cerebral cortex
24. In vivo imaging of human cerebral acetylcholinesterase
25. 11C]physostigmine
26. Cholinergic deficit in Alzheimer's disease: A study based on CSF and autopsy data
27. Anatomical atlas of the baboon's brain in the orbito-meatal plane used in experimental positron emission tomography
28. Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and nondemented patients with Parkinson's disease
29. Pharmacokinetics of physostigmine in the rat after intravenous administration
30. In vivo visualization of acetylcholinesterase with positron emission tomography
31. 11C]methyl-tetrahydroaminoacridine (methyl-tacrine) in baboon brain
32. 11C]physostigmine, a PET tracer for acetylcholinesterase
33. Active-site catalytic efficiency of acetylcholinesterase molecular forms in Electrophorus, Torpedo, rat and chicken